Projects
|
Projects |
Title |
TARGETS
|
T1.1 |
New therapeutic targets to treat heart failure.
|
T1.2
|
New therapeutic targets to treat pulmonary arterial hypertension
|
| T2 |
The chemokine SDF-1/CXCL12 and its receptors as targets of new antagonists for treatment of inflammation, immune deficiency and cancer. |
| T3.2 |
TCTP-IMat: Translationnaly Controlled Tumor Protein Inhibition-Maturation. |
iCROC
|
Identification of new Combinatory strategies for improving Radiotherapy withOut increasing Cardiovascular side effects.
|
RetroTargetIS
|
Identification of the cellular and molecular targets mediating the immunosupressive properties of retroviral envelope proteins, and of candidate inhibitory compouds.
|
RESISTANCE
|
R1 |
Targeting carbapenemases for fighting antibiotic-resistant Gram-negative bacteria. |
| R2 |
Prediction of effectiveness and understanding of treatment failures in patients with rheumatoid arthritis with biotherapies. |
R3
|
Antileishmanial agents targeting host cell trafficking
|
DELIVERY
|
D1 |
Novel multifunctional drug carriers to address novel drugs in heart and pulmonary diseases.
|
| Part. |
T1.1 |
T1.2
|
T2 |
T3.2 |
R1 |
R2 |
R3
|
D1 |
iCROC
|
RetroTargetIS
|
| 2 |
|
|
|
|
|
|
|
|
|
|
| 3 |
|
|
|
|
|
|
|
|
|
|
| 4 |
|
|
|
|
|
|
|
|
|
|
| 5 |
|
|
|
|
|
|
|
|
|
|
| 6 |
|
|
|
|
|
|
|
|
|
|
| 7 |
|
|
|
|
|
|
|
|
|
|
| 8 |
|
|
|
|
|
|
|
|
|
|
| 9 |
|
|
|
|
|
|
|
|
|
|
| 10 |
|
|
|
|
|
|
|
|
|
|
| 11 |
|
|
|
|
|
|
|
|
|
|
| 12 |
|
|
|
|
|
|
|
|
|
|
| 13 |
|
|
|
|
|
|
|
|
|
|
| 14 |
|
|
|
|
|
|
|
|
|
|
| 15 |
|
|
|
|
|
|
|
|
|
|
| 16 |
|
|
|
|
|
|
|
|
|
|
| 17 |
|
|
|
|
|
|
|
|
|
|
Prediction of effectiveness and understanding of treatment failures in patients with rheumatoid arthritis with biotherapies.
